PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response
Clinical trial NCT03098862 · COMPLETED
Trial details
- NCT number
- NCT03098862
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-09-04
- Primary completion
- 2019-02-28
- Enrollment
- 4830
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.